Longevity.Technology (@LongevityTech)· LongevityTech·· 16 天前评分8
长寿生物科技报告：管线估值2300亿美元
Inside the $230 billion our new *Longevity Biotech Report* says the pipeline is already worth – no regulatory rewrite required.
导读
我们全新的《长寿生物科技报告》指出，该管线估值已达2300亿美元——无需监管重写。 https://vist.ly/5k4yr #longevity #biotech #longevitybiotech #healthspan #aging
来源：Longevity.Technology (@LongevityTech) · x.com